ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,872.16
-2.95%
Dow Jones
42,326.87
-2.58%
US Dollar vs MXN
20.3734
-0.09%
Brent Oil
72.69
-0.06%
Bitcoin
100,728.33
0.66%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Arcus Biosciences Inc (RCUS)

  7. Arcus Biosciences Inc (RCUS) Noticias

Arcus Biosciences Inc

Arcus Biosciences Inc (RCUS)

NYSE
15.17
-0.91
(-5.66%)
Cerrado 18 Diciembre 3:00PM
Delayed by 15 minutes
15.17
0.00
(0.00%)
Fuera de horario: 6:57PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

RCUS Noticias

Solo noticias oficiales

Form 8-K - Current report
Edgar (US Regulatory)
24 Octubre 2024
RCUS (-5.66%)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Edgar (US Regulatory)
23 Octubre 2024
RCUS (-5.66%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
17 Septiembre 2024
RCUS (-5.66%)

Form 8-K - Current report
Edgar (US Regulatory)
27 Agosto 2024
RCUS (-5.66%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 Agosto 2024
RCUS (-5.66%)

RCUS Discussion

Ver más
Monksdream Monksdream 3 meses hace
RCUS a buy under $14
👍️0
PennyWorld PennyWorld 1 año hace
https://seekingalpha.com/news/4005456-roche-send-anti-tigit-developers-higher-after-cancer-drug-data?ref=biztoc.com
👍️0
conix conix 3 años hace
Biotechs are starting to react to news...finally.
👍️0
dinogreeves dinogreeves 5 años hace
The stock didn't react as well as expected with the partnership, but it did hi almost my price target. This is a partnership 200 million equity investment and 175 million up front payment, which. implies no offering on the table. Makes you wonder why the stock is down, guess people were expecting a buyout. Some of these people are so lame, unbelievable.
👍️0
lovetc lovetc 5 años hace
Also in the DEF 14.....didnt see any information regarding Gilead....
👍️0
lovetc lovetc 5 años hace
shorted some and bought some put at $31 last Friday....Also today when it reached $30 I short.....I find no reason not to short above $30 lol....It will be $18 soon since the Volumn start declined....
👍️0
dinogreeves dinogreeves 5 años hace
RCUS will likely hit 40 this week and if it does that could essentially mean that there is buyout looming from GI*LD. Someone is buying heavy between 27-29 dollars, obviously they don't want it dip more than 26-27 dollars, it could be a number of reasons that is beyond any retails control.
👍️0
dinogreeves dinogreeves 5 años hace
Bought another 1000 shares on that dip, going to wait this one.
👍️0
dinogreeves dinogreeves 5 años hace
Possible huge asset buy, or outright buyout coming from GILD or even a partnership.
👍️0
dinogreeves dinogreeves 5 años hace
RCUS getting ready to pop to 33-35 dollars.
👍️0
dinogreeves dinogreeves 5 años hace
This is my letter to the shorts with margin account


That is where dummies like you are mistaken. If GILD places anywhere close to that dollar amount this stock jumps over triple digits in less then 2 hours and if there is buyout it won't even let you blink, just one share will it to the buyout price. If GOOGLE has 17% stake on this company and GILD is looking to either buy or take a stake, there must be something that you and I are not aware of the current directors sold their pervious company to Bristol for 1.5 billion dollars. There is more here than meets the eye. I am taking my chance because if no balls no glory and when that happens short margin account will be vaporized.


https://markets.businessinsider.com/news/stocks/arcus-biosciences-stock-spikes-reports-gilead-investing-cancer-drug-biotech-2020-4-1029100118
👍️0
dinogreeves dinogreeves 5 años hace
If this happens the stock will shoot up to over $200 dollars in an instant. Only if that happens.



https://markets.businessinsider.com/news/stocks/arcus-biosciences-stock-spikes-reports-gilead-investing-cancer-drug-biotech-2020-4-1029100118
👍️0
dinogreeves dinogreeves 5 años hace
News could come from GI*LD that there is a buyout. Watch for news.
👍️0

Su Consulta Reciente

NYSE
RCUS
Arcus Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados